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Abstract
Reliable and valid biomarkers of ageing (BoA) are needed to understand mechanisms, test interventions and predict the
timing of adverse health events associated with ageing. Since increased reactive oxygen species (ROS) production and
mitochondrial dysfunction are consequences of cellular senescence and may contribute causally to the ageing of organisms,
we focused on these parameters as candidate BoA. Superoxide levels, mitochondrial mass and mitochondrial membrane
potential in human peripheral blood mononuclear cells (PBMCs) and subpopulations (lymphocytes and monocytes) were
measured in participants from the Newcastle 85+ study, a population-based study of the very old (aged 85 years and older).
The intra- and inter-assay precision expressed as coefficient of variation (CV) for all parameters was acceptable (3% to 12%
and 5 to 22% respectively). All parameters were stable in the short-term (1 week interval) in a sample of control individuals
in the PBMCs and lymphocyte subpopulation, however they were unstable in the monocyte subpopulation; this rendered
monocytes unreliable for further analysis. There was a significant association between superoxide levels and mitochondrial
mass (positive in lymphocytes, p = 0.01) and between superoxide levels and mitochondrial membrane potential (negative in
PBMCs, p = 0.01; positive in lymphocytes, p = 0.05). There were also significant associations between superoxide levels and
mitochondrial parameters with other markers of oxidative stress-induced cellular senescence (p#0.04), however some were
in the opposite direction to expected. No associations were found between the measured parameters and age-related
outcomes, including cognitive impairment, disability, co-morbidity and survival - questioning the validity of these
parameters as candidate BoA in the very old.
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Introduction
The United Kingdom, like other high income countries, is
undergoing dramatic changes in the age structure of its population
due to increasing life expectancy and thus continuing growth in
the older population [1]. Since the older population are more
vulnerable to longstanding illnesses and disabilities and report the
worst self-rated health, a major concern is an increase in the
number of morbid years towards the end of life [2]. This highlights
the importance of understanding the complex biology of ageing
and its association with frailty and disease [3]. There are
considerable differences between individuals with respect to the
rate and extent of age-related decline, driven by a combination of
genetic, stochastic and environmental factors [4]. Thus there is a
need to find biological measurements that can discriminate
between individuals who share the same ‘‘chronological age’’ but
differ in their ‘‘biological age’’. These so-called biomarkers of
ageing (BoA) will be useful to understand mechanisms, test
interventions and predict the timing of adverse health events
associated with ageing [5]. Many candidate BoA have been
proposed, including various anthropometric, physical, physiolog-
ical, haematological and biochemical parameters. However, there
are inconsistencies between studies and to date there are no
measurements that meet the full criteria of a BoA [5]. Advances in
the study of the biological mechanisms of ageing have identified
various cellular and molecular markers, although there is little
information on their role as BoA within the population, especially
in older age groups.
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Reactive oxygen species (ROS) are highly reactive molecules
that contain an unpaired electron capable of taking an electron
away from a target molecule in order to restore its stable state.
ROS are important in many biological processes such as
prostaglandin synthesis, immune defences, various enzymatic
reactions and cell signalling processes. However, under certain
circumstances, antioxidant defences become less efficient and
ROS can cause structural damage to surrounding molecules
including lipids, proteins and DNA. This results in the dysregu-
lation of physiological functions increasing vulnerability to
detrimental health outcomes [6].
Mitochondria are the major source of ROS within a cell. The
main function of the mitochondria is the production of metabolic
energy in the form of adenosine triphosphate. Although most of
the oxygen consumed by the mitochondrial electron transport
chain is reduced to water, a small proportion is converted to ROS,
which may reach 1–2% in isolated mitochondria under specific
experimental conditions [7]. Mitochondria themselves are a major
target of the ROS they produce and are therefore subject to high
levels of ROS-induced damage [8]. This in turn may induce
further ROS production, when enzymes in the electron transport
chain of the mitochondria become damaged directly or indirectly
by ROS [9,10]. Several studies have shown the relevance of
increased ROS production from dysfunctional mitochondria as a
major driving force in cellular ageing (Figure 1). ROS production
and mitochondrial dysfunction are therefore potential BoA.
There are various steps to consider when investigating
candidate BoA. Firstly, the degree of measurement reliability
needs to be established. This is critically important in population
studies to ensure the variability of the candidate BoA reflects
genuine inter-individual differences and not measurement error.
Therefore evidence of experimental and intra-individual stability
should be shown. Experimental stability concerns various handling
factors during preparation and analysis where significant effects
can be controlled during experimentation. Intra-individual stabil-
ity concerns factors of an individual that may impact on the day-
day repeatability of the candidate BoA which can be controlled
before experimentation or using statistical approaches during
analysis [11]. Secondly, evidence of construct validity should be
shown, which is the ability of a measurement to reflect known
characteristics of the construct being investigated, in this case
biological ageing [12]. BoA should therefore reflect known
mechanisms of ageing and be associated with age-related
outcomes [5]. Thirdly and most importantly, BoA should be able
to predict the years of remaining good health and the trajectory
towards a wide range of age-related outcomes and mortality better
than chronological age [5,13].
We aimed to assess 1) the reliability of superoxide levels,
mitochondrial mass and mitochondrial membrane potential
measurements in peripheral blood mononuclear cells (PBMCs)
by flow cytometry and 2) their validity as potential BoA in a
population-based longitudinal study of a birth cohort of the very
old population (aged 85 years and older). Despite establishing
methodological reliability, we did not find any predictive power in
terms of longevity or age-related health outcomes in this age
group.
Materials and Methods
Participants
This study was nested in the Newcastle 85+ study, a population-
based cohort study of health and ageing in the very old, the
methodology for which has been reported [14–16]. In brief, all
surviving adults born in 1921, who turned 85 in 2006 when the
study commenced and were permanently registered with a
participating general practice in Newcastle upon Tyne or North
Tyneside (North-East England) were invited to participate. People
living in institutions and those with cognitive impairment were
included. Participants were visited by a research nurse at their
usual place of residence (i.e. their own home, care home, nursing
home or residential home) at baseline (phase 1: 2006–7, n= 854),
18 months (phase 2: 2007–9, n= 631) and 36 months (phase 3:
2009–10, n = 484). Attrition between phases 1 and 3 was mainly
due to deaths (62.7%, 232/370) with the remainder due to drop
out. The study population at baseline was sociodemographically
representative of the local (Newcastle upon Tyne and North
Tyneside) and wider (England and Wales) population [15]. At
each phase, a multi-dimensional health assessment was undertaken
including questionnaires, physical measurements, function tests
and blood sample measurements. Data reported here are from the
phase 3 assessment (participants aged 88–89 years) unless
otherwise stated. Control blood samples from anonymous
volunteers were also collected for experimental analysis. Ethical
approval was obtained from the Newcastle and North Tyneside 1
Research Ethics Committee (reference number 06/Q0905/2);
written informed consent was obtained from either participants or
from a consultee, usually a relative or carer, when participants
lacked capacity to consent.
ROS production and mitochondrial function
measurements by flow cytometry
PBMCs from 6 ml lithium-heparin blood samples were isolated
by density gradient centrifugation. Around 16105 cells were
resuspended in 1 ml of RPMI medium (Sigma, Poole, UK) with
Figure 1. ROS production from dysfunctional mitochondria as
the driving force of cellular ageing. ROS accelerates the onset of
replicative senescence by increasing the rate of telomere shortening
[42,43] as well as feeding into a continuous DNA damage response that
sustains the accumulation of inflammatory mediators as part of the
senescence-associated secretory phenotype (SASP), and mitochondrial
dysfunction, defined as enhanced production of superoxide together
with (frequently) increased mitochondrial mass and decreased mito-
chondrial membrane potential. This maintains an irreversible state of
persistent damage in senescent cells [22,44]. The subsequent dysreg-
ulation of physiological function contributes to age-related pathology
and/or carcinogenesis [45,46].
doi:10.1371/journal.pone.0091005.g001
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either 10 mM dihydroethidium (DHE) (Life Technologies, Invitro-
gen, Paisly, UK) to measure superoxide levels, 100 nM Mito-
Tracker Green FM (Life Technologies, Invitrogen, Paisly, UK) to
measure mitochondrial mass or 7.7 mM 5,59,6,69-tetrachloro-
1,19,3,39-tetraethylbenzimidaz olylcarbocyanine iodide (JC-1) (Life
Technologies, Invitrogen, Paisly, UK) to measure mitochondrial
membrane potential and incubated at 37uC for 30 minutes. RPMI
medium alone was used as an unstained control. After incubation,
cells were washed once and finally resuspended in 2 ml of RPMI
medium. Samples were assessed immediately by flow cytometry on
a Partec PAS system (Partec, Munster, Germany). Around 16104
events (cells) were analysed per sample. PBMCs, lymphocytes and
monocytes were first identified based on their size and granularity
[17] (Figure S1A.i, B.i and C.i in File S1). The mean fluorescence
of unstained cells was recorded and subtracted from the
fluorescence values measured in the stained cells, identified using
the same gating as for the unstained cells. To confirm that the
unstained cell population were red blood cells, and therefore
correctly excluded, red blood cells were lysed before staining in a
separate experiment (Figure S1A.ii, B.ii and C.ii in File S1). This
was also confirmed by staining unlysed and lysed samples with 2 ml
PerCP Mouse Anti-Human CD45 to identify PBMCs (lympho-
cytes sand monocytes) (Pharmingen, BD Biosciences, San Jose,
CA, USA) in 1 ml RPMI medium (Figure S1D.i. and ii in File S1
respectively). Correct distinction between lymphocytes and
monocytes by size/granularity was confirmed with a parallel
experiment performed in a subset of control samples where 16105
cells were incubated with 2 ml PerCP Mouse Anti-Human CD45
in 1 ml RPMI medium to identify both lymphocytes and
monocytes and 6 ml FITC Mouse Anti-Human CD14 (Pharmin-
gen, BD Biosciences, San Jose, CA, USA) in 1 ml RPMI medium
to identify monocytes only (Figure S1E in File S1).
Other biomarkers measured in the Newcastle 85+ Study
Other biomarkers included in this analysis were those consid-
ered as potential markers of oxidative stress-induced cellular
senescence (see Figure 1) including: plasma 8-isoprostanes as a
marker of oxidative stress; PBMC telomere length as a marker of
telomere shortening; ionized radiation-induced DNA damage and
repair capacity of PBMCs as markers of DNA damage and repair;
immunosenescence of PBMC subpopulations (as percentage of
CD27-/RO- CD4 and CD8 T lymphocyte cells) as markers of
cellular senescence; and interleukin-6 (IL-6), tumour necrosis
factor-alpha (TNF-a) and high sensitivity C-reactive protein
(hsCRP) as markers of inflammation. Additional physical,
physiological, haematological and biochemical measurements that
were previously confirmed as informative BoA in the Newcastle
85+ study [18] also included were: hand grip strength, timed up
and go test (TUG), lung forced expiratory volume in 1 second
(FEV1) (at phase 1), systolic blood pressure, haematocrit,
haemoglobin, red blood cell count, free triiodothyronine (Free
T3), vitamin D (at phase 1) and N-terminal pro b-type natriuretic
peptide (NT-pro BNP). Details of the methology for all of these
biomarkers have been reported [18] and are given as supplemen-
tary methods in File S1.
Age-related outcomes
The procedures for the evaluation of cognitive impairment,
disability score and count of chronic diseases have been reported
[15]. Survival was calculated from date of biomarker measurement
to death or censored at 30/04/2012.
Statistical Analysis
For experimental data, the Student’s t-Test was used to test
differences between two samples, the coefficient of variation (CV,
%) was used to assess assay precision and Pearson’s correlation
coefficient was used to test the strength of association between two
continuous variables. Superoxide levels, mitochondrial mass and
mitochondrial membrane potential each had a non-normal
distribution in the study population, assessed using the Kolomo-
gorov-Smirnov test for normality (p,0.05). We therefore used
Spearman’s correlation to test for the relationship between two
continuous variables, Mann-Whitney U to test for the association
between two groups and Kruskal-Wallis to test for the association
between three or more groups. To test associations with survival,
participants were divided into quartiles of superoxide levels,
mitochondrial mass and mitochondrial membrane potential with
the middle two quartiles grouped together to form the reference
category to represent medium levels. Cox regression was used to
test for the association between grouped variables and survival. p-
values ,0.05 were considered statistically significant. Since many
of the markers are expected to have strong correlations with each
other, reflecting common biological mechanisms, we did not apply
a formal statistical correction for multiple comparisons since this
would have been over-conservative. Sensitivity analysis was
carried out by removing extreme outliers which were values more
than 3 times the interquartile range (IQR) below the 25th or above
the 75th percentiles, which were identified by default in SPSS
boxplots. Potential confounders investigated were gender, marital
status, housing, having had any higher education and physical
activity. Data analysis was performed using SPSS version 19.0.
Results
Reliability of ROS production and mitochondrial function
measurements in PBMCs
To ensure that PBMC superoxide levels, mitochondrial mass
and mitochondrial membrane potential remained stable between
sample handling and flow cytometry analysis, various factors that
may affect their stability were investigated in control samples
(Table S1 in File S1). There was no significant effect after 2 hours
storage of samples at 37uC prior to staining for any of the
parameters, but after 24 hours of storage at 37uC a significant
increase of DHE signals could be observed (p,0.01), independent
of mitochondrial mass and mitochondrial membrane potential. All
parameters were affected by frozen storage of cells in 90% foetal
bovine serum and 10% dimethyl sulfoxide. Following storage at
270uC, DHE signals increased (p,0.01) and the JC1 ratio
indicating mitochondrial membrane potential decreased
(p = 0.02), however there was no change in the mitotracker signal.
Following storage at 2196uC, DHE and mitotracker signal
intensities increased while the JC1 ratio decreased (p,0.01).
These changes might reflect damage to the cells during freezing/
thawing. There was no significant effect of vortex-mediated
mechanical stress for any of the parameters. Removing red blood
cells by lysing them significantly stressed the remaining PBMCs as
evidenced by increased superoxide levels and decreased mito-
chondrial membrane potential (p = 0.01). There was no significant
effect on repeatedly freeze-thawing DHE, MitoTracker Green FM
or JC-1 stain solutions before cell staining on all parameters for up
to 10 cycles. There was no effect of light exposure on stained cells
(i.e. stained samples were either light protected with foil or light
exposed) but there was a significant effect of staining temperature
on all parameters.
After considering the above experimental variables, the
reliability of our flow cytometry method to evaluate ROS
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production and mitochondrial function in PBMCs and subpopu-
lations was assessed by calculating the average intra- and inter-
assay CV of three individual control samples of the same age. The
intra- and inter-assay precision of all parameters in all cell
subpopulations was acceptable [19]; superoxide levels measured
by DHE showed an intra- and inter-assay CVs of 5–7%,
mitochondrial mass measured by MitoTracker Green FM showed
intra-assay CV of 3–10% and inter-assay CV of 11–13% and
mitochondrial membrane potential measured by JC-1 showed
intra-assay CV of 6–12% and inter-assay CV of 11–22%.
To evaluate the intra-individual stability of the parameters and
the day-day reproducibility of our whole experimental procedure,
6 individual control blood samples were taken on two occasions
with an interval of one week and samples were processed
independently (Figure S2 in File S1). Measurements of superoxide
levels and mitochondrial mass in total PBMCs and lymphocytes
were strongly correlated at both time points (r$0.66) and showed
acceptable CVs (4%–8%); however measurements in monocytes
showed little correlation (r#0.19) despite acceptable CVs (12%
and 13%). Measurements of mitochondrial membrane potential
strongly correlated in PBMCs and lymphocytes (r$0.64) but
showed large CVs between time points (39% and 24%) and
measurement in monocytes showed little correlation between time
points (r = 0.25) and also a large CV (57%). Since all the
parameters were unstable in the monocyte subpopulation, further
measurement of the parameters in monocytes were excluded.
Table 1. Descriptive statistics of biomarker measurements.
Descriptives
Biomarker Mean SE Median IQR n
ROS production and mitochondrial dysfunction
Superoxide levels (AU)
PBMCs 37.99 1.15 33.94 20.17 248
Lymphocytes 29.39 1.11 25.39 20.81 248
Mitochondrial mass (AU)
PBMCs 43.35 0.89 41.69 19.99 341
Lymphocytes 51.43 1.75 44.6 32.06 341
Mitochondrial membrane potential (AU)
PBMCs 3.16 0.07 2.86 0.98 347
Lymphocytes 4.24 0.10 3.85 2.00 347
Oxidative stress
8-Iso Prostaglandin F2a (ng/ml) 2.69 0.16 1.49 2.08 379
Telomere shortening
Telomere length (bp) 2825.03 37.55 2715.77 1057.17 430
DNA damage and repair
DNA damage (%) 46.22 0.91 47.26 29.65 431
DNA repair (%) 48.47 1.35 46.24 47.27 431
Immunosenescence
CD27-/RO- CD4 T lymphocytes (%) 4.10 0.35 1.46 3.32 429
CD27-/RO- CD8 T lymphocytes (%) 24.66 0.85 21.81 25.69 403
Inflammation
Il-6 (pg/ml) 539.55 133.85 10.25 31.43 430
TNF-a (pg/ml) 37.64 9.86 2.55 4.42 430
hsCRP (mg/l) 5.63 0.63 2.40 3.70 434
Informative BoA
Hand grip strength (kg) 17.06 0.35 16.10 9.03 453
TUG (seconds) 21.52 0.94 17.09 12.19 402
FEV1 (l)
P1 144.55 1.94 137.00 71.75 776
Systolic blood pressure (mmHg) 143.04 0.96 144.00 28.00 462
Haematocrit (%) 0.39 0.00 0.39 0.05 427
Haemoglobin (g/dl) 12.90 0.07 13.00 1.70 427
Red blood cells (x 1012/l) 4.25 0.02 4.25 0.62 427
Free T3 (pmol/l) 4.39 0.03 4.40 0.80 426
Vitamin D (nmol/l)P1 45.36 0.94 39.00 37.00 778
NT-pro BNP (pg/ml) 848.21 89.05 514.00 791.75 124
(SE: Standard error, IQR: Interquartile range, n: Number of participants, P1Baseline (phase 1)).
doi:10.1371/journal.pone.0091005.t001
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Analysis of ROS production and mitochondrial function
within the Newcastle 85+ study
The experimental variables found to affect ROS production
and mitochondrial function in the control samples were considered
in the measurements conducted within the Newcastle 85+ cohort
to avoid measurement error (i.e. all samples included were stored
for less then 24 hours, were not frozen before analysis, were not
subject to red blood cell lysis and were stained at strictly 37uC for
30 minutes). Descriptive statistics of superoxide levels, mitochon-
drial mass and mitochondrial membrane potential as well as other
biomarkers measured within this study are shown in Table 1.
Superoxide levels were significantly associated with mitochondrial
mass (positive in PBMCs: p= 0.04; positive in lymphocytes:
p = 0.01) and mitochondrial membrane potential (negative in
PBMCs, p = 0.01; positive in lymphocytes, p = 0.04) (Table S2 and
Figure S3 in File S1). Sensitivity analysis removed the significance
of the association between superoxide levels and mitochondrial
mass in the PBMC population (p= 0.13), however the significance
still remained in the lymphocyte subpopulation (p= 0.01) (Table
S3 in File S1). All other significant correlations and direction of
associations remained after sensitivity analysis. Superoxide levels,
mitochondrial mass and mitochondrial membrane potential were
not associated with gender, marital status, housing, having had any
higher education or physical activity (data not shown).
We next tested the association between ROS production and
mitochondrial function with other biomarkers considered as
potential markers of oxidative stress-induced cellular senescence
(see Figure 1). There were consistent associations (i.e. for more
than one cell population) between mitochondrial mass and
telomere length (positive, p#0.04), between superoxide levels
and DNA repair activity (negative, p#0.02) and between
superoxide levels and levels of the pro-inflammatory cytokines Il-
6 and TNF-a (negative, p,0.01) (Table 2 and Figure S4 in File
S1). Sensitivity analysis by removing extreme outliers did not affect
the significance or the direction of association (Table S4 and
Figure S5 in File S1).
Previously we had confirmed 10 out of a list of 72 candidate
markers as informative BoA in the Newcastle 85+ study because
they were associated with two or more of the following age-related
outcomes: cognitive impairment, disability score, disease count
and survival [18]. We therefore tested the association between
ROS production and mitochondrial function with the 10
Table 2. Superoxide levels, mitochondrial mass and mitochondrial membrane potential in relation to other potential markers of
oxidative stress induced cellular senescence.
Superoxide levels Mitochondrial mass Mitochondrial membrane potential
PBMCs Lymphocytes PBMCs Lymphocytes PBMCs Lymphocytes
8-iso Prostaglandin F2a r 20.05 20.03 0.06 0.03 0.03 0.02
p 0.45 0.65 0.34 0.64 0.62 0.77
n 216 216 302 302 304 304
Telomere length r 0.11 0.08 0.11 0.13 0.13 0.04
p 0.08 0.23 0.04 0.02 0.01 0.41
n 248 248 340 340 345 345
DNA damage r 20.06 20.09 0.05 20.03 0.03 0.03
p 0.33 0.16 0.38 0.53 0.63 0.64
n 248 248 341 341 347 347
DNA repair r 20.16 20.15 20.06 20.07 0.06 20.03
p 0.01 0.02 0.26 0.21 0.24 0.59
n 248 248 341 341 347 347
CD27-/RO- CD4 T lymphocytes r 20.11 20.07 0.08 0.08 0.04 20.01
p 0.09 0.31 0.15 0.13 0.42 0.91
n 246 246 339 339 344 344
CD27-/RO- CD8 T lymphocytes r 20.09 20.04 0.09 0.08 0.03 20.02
p 0.17 0.57 0.12 0.14 0.62 0.75
n 237 237 317 317 323 323
Il-6 r 20.31 20.32 20.02 20.05 20.07 20.15
p 0.00 0.00 0.72 0.31 0.23 0.00
n 247 247 340 340 345 345
TNF-a r 20.23 20.23 20.03 20.05 20.03 20.11
p 0.00 0.00 0.60 0.33 0.58 0.04
n 247 247 340 340 345 345
hsCRP r 0.08 0.11 0.03 0.00 20.10 20.01
p 0.19 0.08 0.56 0.94 0.05 0.81
n 248 248 341 341 347 347
(r: Spearman’s correlation coefficient, p: probability, n: number of participants).
doi:10.1371/journal.pone.0091005.t002
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informative BoA (Table 3 and Figure S6 in File S1). No consistent
associations (i.e. for more than one cell population) were found
however significant associations were found in lymphocytes
between Free T3 with mitochondrial membrane potential
(p = 0.03) and baseline vitamin D levels with superoxide levels
(p = 0.04) and mitochondrial membrane potential (p,0.01).
Sensitivity analysis by removing extreme outliers reduced the
significance of the association between superoxide levels and
vitamin D in the lymphocyte subpopulation (p = 0.08) however the
association between Free T3 and vitamin D with mitochondrial
membrane potential in the lymphocyte subpopulation remained
(p#0.03) (Table S5 and Figure S7 in File S1).
The association between ROS production and mitochondrial
function and age-related outcomes including cognitive impair-
ment, disability and count of chronic diseases (Table 4) and
survival (Figure 2) in this sample of the very old was investigated.
No significant associations were found between superoxide levels
or the mitochondrial parameters with cognitive impairment,
disability, disease count or survival. This was not changed
following removal of outliers (Table S6 in File S1).
Discussion
We provide evidence for the methodological reliability of
measuring superoxide levels, mitochondrial mass and mitochon-
drial membrane potential by flow cytometry in PBMCs and
lymphocyte subpopulations. We did not however find evidence for
their validity as predictors of age-related health outcomes or
survival in the very old.
Assessing the reliability of potential BoA is critically important
in population studies to ensure that variability reflects genuine
inter-individual differences and not methodological error. This
study aimed to evaluate measurement error by investigating
variables that may affect the experimental stability of ROS
production and mitochondrial function as potential BoA. Vari-
ables found to affect the stability of the markers in PBMCs during
preparation before flow cytometry analysis were: sample storage at
Table 3. Superoxide levels, mitochondrial mass and mitochondrial membrane potential in relation to informative BoA.
Superoxide levels Mitochondrial mass Mitochondrial membrane potential
PBMCs Lymphocytes PBMCs Lymphocytes PBMCs Lymphocytes
Hand grip strength r 0.01 0.00 20.02 20.05 20.06 20.01
p 0.85 0.95 0.71 0.35 0.29 0.87
n 242 242 336 336 342 342
TUG r 20.01 20.01 0.03 0.05 0.06 0.07
p 0.94 0.91 0.64 0.37 0.30 0.23
n 218 218 304 304 312 312
FEV1P1 r 0.07 0.06 0.02 20.04 0.01 20.01
p 0.29 0.32 0.77 0.49 0.85 0.83
n 244 244 335 335 341 341
Systolic blood pressure r 0.02 20.02 0.07 0.09 0.01 0.01
p 0.77 0.79 0.22 0.09 0.92 0.87
n 245 245 338 338 343 343
Haematocrit r 0.06 0.07 0.05 20.03 20.04 20.05
p 0.37 0.26 0.35 0.53 0.49 0.36
n 246 246 338 338 343 343
Haemoglobin r 0.05 0.07 0.08 20.01 0.01 20.06
p 0.44 0.25 0.16 0.81 0.82 0.29
n 246 246 338 338 343 343
Red blood cells r 0.08 0.12 0.10 0.05 20.03 20.08
p 0.20 0.07 0.08 0.36 0.6 0.13
n 246 246 338 338 343 343
Free T3 r 20.09 20.11 0.03 20.04 20.07 20.12
p 0.16 0.08 0.61 0.51 0.19 0.03
n 246 246 338 338 343 343
Vitamin DP1 r 20.12 20.13 20.01 20.05 20.10 20.18
p 0.06 0.04 0.89 0.35 0.06 00.0
n 240 240 331 331 338 338
NT-pro BNP r 20.10 20.19 20.09 20.17 20.10 0.11
p 0.50 0.19 0.39 0.12 0.33 0.30
n 46 46 85 85 95 95
(r: Spearman’s correlation coefficient, p: probability, n: number of participants, P1Phase 1 data).
doi:10.1371/journal.pone.0091005.t003
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37uC for 24 hours; freezing at 270uC and 2196uC; removing red
blood cells by lysis; and the staining temperature of cells. Short
term sample storage (37uC for 2 hours), vortex mediated
mechanical stress, stain freeze-thaw cycles (up to 10 cycles) and
not protecting samples from light exposure during staining did not
influence the markers. The study also showed that all markers
were stable within individuals during a seven day interval in the
PBMC and lymphocyte populations but not in the monocyte
population. It is therefore unlikely that intra-individual factors will
contribute to measurement error in the short term within the two
former cell populations however this could be the case within the
monocyte population. In support of this, monocyte populations
have been shown to have a weaker diurnal rhythm than
lymphocytes and other PBMC subpopulations which demonstrates
that they may be more sensitive to intra-individual factors [20],
which could affect ROS production and mitochondrial function.
One potential intra-individual factor is sleep quality since different
PBMC subpopulation levels have different sensitivities to sleep
deprivation [20]. Other potential causes of intra-individual
variation that could be explored in future analysis include diet,
smoking, alcohol consumption, medications, illnesses and other
key events. The seven day interval experiment also demonstrated
good day-day repeatability of the flow cytometry analysis for
superoxide and mitochondrial mass but not for mitochondrial
membrane potential. A potential problem with the JC-1 dye for
measuring mitochondrial membrane potential is that it is poorly
soluble in aqueous solutions [21] and thus variation in the
preparation of the stain on different occasions could be the reason
for its day-day variability.
We have previously found in human fibroblasts, and in a
number of other tissues, that high mitochondrial ROS production,
high mitochondrial mass and low mitochondrial membrane
potential are associated with cell senescence [22–26]. While the
association of high mitochondrial mass with telomere dysfunction
and senescence has been contested [27], increases in ROS and
decreases in mitochondrial functionality, typically associated with
low mitochondrial membrane potential, have commonly been
found in ageing and senescence [28–31]. We therefore expected to
find robust associations between ROS production and mitochon-
drial dysfunction with a range of other senescence-associated
parameters in the peripheral blood samples from the Newcastle
85+ study. This was not the case; typically most correlations were
either absent or opposed to the expected direction. Although
superoxide levels and mitochondrial membrane potential were
negatively associated in PBMCs, as seen in senescent fibroblasts
[23], this association was reversed in lymphocytes. This could
potentially be due to a non-linear association between ROS
production and mitochondrial membrane potential. It might also
suggest that ROS levels observed in lymphocytes from the
Newcastle 85+ study participants are not primarily driven by cell
senescence.
This study also attempted to validate superoxide levels and
mitochondrial dysfunction as BoA by determining their agreement
with 10 informative BoA identified in a previous investigation of
the Newcastle 85+ study cohort [18]. Increased mitochondrial
membrane potential in Phase 3 lymphocytes significantly corre-
lated with decreased serum Vitamin D levels in Phase 1. Although
it has been shown there is a moderate intra-individual variation in
vitamin D over approximately five years, a high correlation was
observed, supporting the use of a one-time measurement of
vitamin D within 5 years [32]. We would therefore expect vitamin
D levels at phase 3 to show the same association to mitochondrial
membrane potential as phase 1 levels. However vitamin D
supplementation and season of blood draw affects the reliability of
repeat measures. The association between mitochondrial mem-
brane potential and vitamin D levels could therefore be stronger if
we had measurements at the same time point. This could be worth
further investigation. Mitochondrial membrane potential also
significantly correlated with free T3. Since vitamin D levels and
thyroid hormones vary with the season in the older population
Figure 2. Association between PBMC superoxide levels,
mitochondrial mass, mitochondrial membrane potential and
survival. (Cox regression analysis)
doi:10.1371/journal.pone.0091005.g002
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[33], this suggests that mitochondrial function could also be
affected by seasonality. There were no other associations found
between superoxide levels or mitochondrial parameters and the
other eight remaining informative BoA.
Further attempts to validate ROS production and mitochon-
drial parameters as BoA were made by investigating their
association with age-related outcomes in the very old, as in the
previously reported study of this cohort by Martin-Ruiz et al,
2011. No associations were found between ROS production or the
mitochondrial parameters with cognitive impairment, disability
score, disease count or survival. However, since the very old have a
high prevalence of chronic conditions, including hypertension,
osteoarthritis and sensory impairment [15], this study could be
confounded by the presence of other age-related outcomes. A
more general approach could be to investigate the association
between potential BoA and frailty. A previous analysis in the
Newcastle 85+ study identified the importance of inflammatory
markers in frailty in the oldest old [34]. However limited evidence
was found for the role of immunosenescence in frailty and no
evidence for the role of telomere length, markers of oxidative
damage or DNA damage and repair. Furthermore, a recent
analysis in the same cohort found no association between frailty
and mitochondrial DNA haplogroups [35]. These are maternally
inherited variations in mitochondrial DNA (mtDNA) sequences
for which the population can be divided into several groups based
on specific nucleotide polymorphisms (SNPs) variants. It is thought
that some variants of mitochondrial DNA haplogroups have
functional differences including lower rates of ROS production
and better capacity to cope with oxidative stress [36,37] and
several studies have shown associations with various age-related
outcomes [38–41]. However there are inconsistencies regarding
which variant is more susceptible to age-related outcomes. A
limitation, along with this study in relation to cognitive impair-
ment, disability score and disease count, is that analysis was cross-
sectional and longitudinal analysis would be more informative.
Further analysis of this cohort could therefore be to longitudinally
investigate the role of ROS production and mitochondrial
function in the development of frailty within the very old.
Conclusion
This study identified variables that affect the stability of PBMC
ROS production and mitochondrial function during experimental
analysis and provided evidence of their experimental reliability
and intra-individual stability in PBMC and lymphocyte subpop-
ulations. The reason for the individual instability in monocytes
should be further explored. We also provided evidence for the
agreement of PBMC ROS production and mitochondrial function
with some markers implicated in oxidative stress-induced cellular
senescence, however some associations were in the opposite
direction to those expected. We do not however provide evidence
for their validity as markers associated with age-related outcomes
or survival, and therefore as candidate BoA in the very old
population.
Supporting Information
File S1 File S1 includes the following: Figure S1.
Quantification of superoxide levels, mitochondrial mass and
mitochondrial membrane potential in PBMCs and cell subpopu-
lations by flow cytometry. Figure S2. Short term intra-individual
stability and day-day precision of superoxide levels, mitochondrial
mass and mitochondrial membrane potential. Figure S3. Scatter
plots of agreements between superoxide levels, mitochondrial mass
and mitochondrial membrane potential. Figure S4. Scatter plots
of superoxide levels, mitochondrial mass and mitochondrial
membrane potential in relation to other potential markers of
oxidative stress-induced cellular senescence. Figure S5. Scatter
plots of superoxide levels, mitochondrial mass and mitochondrial
membrane potential in relation to other potential markers of
oxidative stress-induced cellular senescence after removal of
extreme outliers. Figure S6. Scatter plots of superoxide levels,
mitochondrial mass and mitochondrial membrane potential in
relation to informative BoA. Figure S7. Scatter plots of
superoxide levels, mitochondrial mass and mitochondrial mem-
brane potential in relation to informative BoA after removal of
extreme outliers. Table S1. Stability of superoxide levels,
mitochondrial mass and mitochondrial membrane potential in
PBMCs during various experimental handling. Table S2.
Agreements between superoxide levels, mitochondrial mass and
mitochondrial membrane potential. Table S3. Agreements
between superoxide levels, mitochondrial mass and mitochondrial
membrane potential after removal of extreme outliers. Table S4.
Superoxide levels, mitochondrial mass and mitochondrial mem-
brane potential in relation to other potential markers of oxidative
stress-induced cellular senescence after removal of extreme
Table 4. Association between superoxide levels, mitochondrial mass, mitochondrial membrane potential and age-related
outcomes.
Superoxide levels Mitochondrial mass Mitochondrial membrane potential
PBMCs Lymphocytes PBMCs Lymphocytes PBMCs Lymphocytes
Disability score r 0.00 0.01 20.03 0.01 0.02 0.07
p 0.95 0.90 0.60 0.83 0.75 0.21
n 247 247 339 339 345 345
SMMSE score r 0.07 0.08 0.08 0.04 0.05 20.08
p 0.25 0.19 0.13 0.44 0.35 0.13
n 247 247 339 339 345 345
Disease count r 0.08 0.08 0.04 0.07 20.03 20.01
p 0.20 0.25 0.46 0.22 0.55 0.90
n 239 239 328 328 334 334
(r: Spearman’s correlation coefficient, p: probability, n: number of participants).
doi:10.1371/journal.pone.0091005.t004
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outliers. Table S5. Superoxide levels, mitochondrial mass and
mitochondrial membrane potential in relation to informative BoA
after removal of extreme outliers. Table S6. Association between
superoxide levels, mitochondrial mass and mitochondrial mem-
brane potential and age-related outcomes after removal of extreme
outliers. Supplementary Methods.
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